Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO19410 | Clutia abyssinica | Species | Peraceae | Eukaryota | UNPD* | |||
NPO21507 | Ephedra intermedia | Species | Ephedraceae | Eukaryota | UNPD* | |||
NPO26309 | Ahnfeltiopsis flabelliformis | Species | Phyllophoraceae | Eukaryota | UNPD* | |||
NPO20431 | Centaurea canariensis | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO20295 | Eclipta prostrata | Species | Asteraceae | Eukaryota | TCM_Taiwan* | |||
NPO20295 | Eclipta prostrata | Species | Asteraceae | Eukaryota | HerDing* | |||
NPO31384 | Thuja orientalis | Species | Cupressaceae | Eukaryota | TCM_Taiwan* | |||
NPO31384 | Thuja orientalis | Species | Cupressaceae | Eukaryota | HerDing* | |||
NPO29633 | Ecliptae herba | NA | NA | NA | TCMSP* | |||
NPO20295 | Eclipta prostrata | Species | Asteraceae | Eukaryota | TM-MC* | |||
NPO15546 | Herba ecliptae prostratae | NA | NA | NA | TCMID* | |||
NPO28256 | Platycladus orientalis | Species | Cupressaceae | Eukaryota | TCMID* | |||
NPO20295 | Eclipta prostrata | Species | Asteraceae | Eukaryota | TCMID* | |||
NPO21382 | Eutypa lata | Species | Diatrypaceae | Eukaryota | UNPD* | |||
NPO17908 | Rhododendron reticulatum | Species | Ericaceae | Eukaryota | UNPD* | |||
NPO11034 | Mnium pseudopunctatum | Species | Mniaceae | Eukaryota | UNPD* | |||
NPO18749 | Corydalis vernyi | Species | Papaveraceae | Eukaryota | UNPD* | |||
NPO21251 | Tabernaemontana odoratissima | Species | Apocynaceae | Eukaryota | UNPD* | |||
NPO19559 | Cetraria pseudocomplicata | Species | Parmeliaceae | Eukaryota | UNPD* | |||
NPO19272 | Alcyonium fauri | Species | Alcyoniidae | Eukaryota | UNPD* | |||
NPO17115 | Kielmeyera petiolaris | Species | Calophyllaceae | Eukaryota | UNPD* | |||
NPO20982 | Morus lactea | Species | Sulidae | Eukaryota | UNPD* | |||
NPO14172 | Rhopaloeides odorabile | Species | Spongiidae | Eukaryota | UNPD* | |||
NPO20233 | Marchantia paleacea | Species | Marchantiaceae | Eukaryota | UNPD* | |||
NPO20718 | Hypericum elegans | Species | Hypericaceae | Eukaryota | UNPD* | |||
NPO2842 | Garcinia lucida | Species | Clusiaceae | Eukaryota | UNPD* | |||
NPO20101 | Eria acutifolia | Species | Orchidaceae | Eukaryota | UNPD* | |||
NPO19837 | Euonymus latifolius | Species | Celastraceae | Eukaryota | UNPD* | |||
NPO3468 | Astragalus floccosifolius | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO20648 | Streptomyces cellulosae | Species | Streptomycetaceae | Bacteria | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT570 | Individual Protein | Arachidonate 5-lipoxygenase | Homo sapiens | IC50 | = | 2500 | nM | 11212092 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | IC50 | = | 700 | nM | 11212092 |
NPT805 | Protein Complex | GABA-A receptor; anion channel | Rattus norvegicus | IC50 | = | 2000 | nM | 11212092 |
NPT982 | Individual Protein | Inhibitor of nuclear factor kappa B kinase alpha subunit | Homo sapiens | IC50 | > | 10000 | nM | 18077363 |
NPT981 | Individual Protein | Inhibitor of nuclear factor kappa B kinase beta subunit | Homo sapiens | IC50 | > | 10000 | nM | 18077363 |
NPT1581 | Individual Protein | Carbonyl reductase [NADPH] 1 | Homo sapiens | Activity | = | 5.8 | % | 19097799 |
NPT1581 | Individual Protein | Carbonyl reductase [NADPH] 1 | Homo sapiens | IC50 | = | 3780 | nM | 19097799 |
NPT1581 | Individual Protein | Carbonyl reductase [NADPH] 1 | Homo sapiens | Ki | = | 600 | nM | 19097799 |
NPT191 | Organism | Hepatitis C virus | Hepatitis C virus | IC50 | = | 36100 | nM | 18947995 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | = | 50118.7 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 2511.9 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 44668.4 | nM | PubChem BioAssay data set | |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | = | 4466.8 | nM | PubChem BioAssay data set |
NPT4005 | Protein Complex | Shiga toxin | Escherichia coli O157:H7 | Potency | = | 7980.5 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 1000 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 707.9 | nM | PubChem BioAssay data set |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 7079.5 | nM | PubChem BioAssay data set |
NPT442 | Individual Protein | Ferritin light chain | Equus caballus | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT442 | Individual Protein | Ferritin light chain | Equus caballus | Potency | = | 50118.7 | nM | PubChem BioAssay data set |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 5011.9 | nM | PubChem BioAssay data set |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 19905.4 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT58 | Individual Protein | Bloom syndrome protein | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT58 | Individual Protein | Bloom syndrome protein | Homo sapiens | Potency | = | 17782.8 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 14125.4 | nM | PubChem BioAssay data set |
NPT4006 | Individual Protein | Telomere resolvase resT | Borrelia burgdorferi (strain ATCC 35210 / B31 / CIP 102532 / DSM4680) | IC50 | = | 8670 | nM | 19596868 |
NPT4006 | Individual Protein | Telomere resolvase resT | Borrelia burgdorferi (strain ATCC 35210 / B31 / CIP 102532 / DSM4680) | Inhibition | = | 70 | % | 19596868 |
NPT4006 | Individual Protein | Telomere resolvase resT | Borrelia burgdorferi (strain ATCC 35210 / B31 / CIP 102532 / DSM4680) | Inhibition | = | 6 | % | 19596868 |
NPT4007 | Individual Protein | Shiga toxin 1 variant A subunit | Escherichia coli O157:H7 | Potency | 36581.9 | nM | PubChem BioAssay data set | |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT4007 | Individual Protein | Shiga toxin 1 variant A subunit | Escherichia coli O157:H7 | Potency | 32603.7 | nM | PubChem BioAssay data set | |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | 3162.3 | nM | PubChem BioAssay data set | |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | 2238.7 | nM | PubChem BioAssay data set | |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | 1258.9 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 751.9 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 1683.4 | nM | PubChem BioAssay data set | |
NPT191 | Organism | Hepatitis C virus | Hepatitis C virus | IC50 | = | 36000 | nM | 22280819 |
NPT888 | Individual Protein | 78 kDa glucose-regulated protein | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT888 | Individual Protein | 78 kDa glucose-regulated protein | Homo sapiens | Potency | 1995.3 | nM | PubChem BioAssay data set | |
NPT191 | Organism | Hepatitis C virus | Hepatitis C virus | IC50 | = | 34000 | nM | 23127989 |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 11.75 | % | 23062825 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 11.14 | % | 23062825 |
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 1778.3 | nM | PubChem BioAssay data set | |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 11220.2 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC86477 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9752 | High Similarity | NPC261471 |
0.975 | High Similarity | NPC78830 |
0.975 | High Similarity | NPC218533 |
0.963 | High Similarity | NPC37606 |
0.9623 | High Similarity | NPC29411 |
0.9512 | High Similarity | NPC164384 |
0.9379 | High Similarity | NPC291110 |
0.9379 | High Similarity | NPC37183 |
0.9341 | High Similarity | NPC97523 |
0.9321 | High Similarity | NPC277480 |
0.9313 | High Similarity | NPC188486 |
0.9308 | High Similarity | NPC196879 |
0.9264 | High Similarity | NPC50394 |
0.9255 | High Similarity | NPC312056 |
0.9255 | High Similarity | NPC84515 |
0.9236 | High Similarity | NPC125300 |
0.9198 | High Similarity | NPC133065 |
0.9187 | High Similarity | NPC16935 |
0.9182 | High Similarity | NPC45131 |
0.9141 | High Similarity | NPC39306 |
0.913 | High Similarity | NPC115432 |
0.913 | High Similarity | NPC300680 |
0.913 | High Similarity | NPC260296 |
0.9114 | High Similarity | NPC41326 |
0.9107 | High Similarity | NPC98546 |
0.9107 | High Similarity | NPC297807 |
0.9091 | High Similarity | NPC202470 |
0.908 | High Similarity | NPC263092 |
0.908 | High Similarity | NPC59295 |
0.908 | High Similarity | NPC39305 |
0.908 | High Similarity | NPC1755 |
0.908 | High Similarity | NPC1706 |
0.908 | High Similarity | NPC89131 |
0.9068 | High Similarity | NPC244750 |
0.9048 | High Similarity | NPC24258 |
0.9042 | High Similarity | NPC310794 |
0.9042 | High Similarity | NPC473834 |
0.903 | High Similarity | NPC247973 |
0.9024 | High Similarity | NPC36320 |
0.9024 | High Similarity | NPC45449 |
0.9018 | High Similarity | NPC238995 |
0.9 | High Similarity | NPC113906 |
0.8994 | High Similarity | NPC101996 |
0.8987 | High Similarity | NPC62042 |
0.8982 | High Similarity | NPC230619 |
0.8982 | High Similarity | NPC28589 |
0.8982 | High Similarity | NPC174700 |
0.8982 | High Similarity | NPC54098 |
0.8982 | High Similarity | NPC248593 |
0.8981 | High Similarity | NPC194856 |
0.8976 | High Similarity | NPC165979 |
0.8976 | High Similarity | NPC163130 |
0.8963 | High Similarity | NPC472278 |
0.8963 | High Similarity | NPC329669 |
0.8963 | High Similarity | NPC473313 |
0.8963 | High Similarity | NPC155640 |
0.8944 | High Similarity | NPC13879 |
0.8941 | High Similarity | NPC183843 |
0.8938 | High Similarity | NPC88645 |
0.8938 | High Similarity | NPC292214 |
0.8938 | High Similarity | NPC271779 |
0.8938 | High Similarity | NPC167091 |
0.8938 | High Similarity | NPC206238 |
0.8938 | High Similarity | NPC89474 |
0.8931 | High Similarity | NPC171010 |
0.8931 | High Similarity | NPC202157 |
0.8929 | High Similarity | NPC82217 |
0.8929 | High Similarity | NPC233956 |
0.8929 | High Similarity | NPC216842 |
0.8929 | High Similarity | NPC476640 |
0.8922 | High Similarity | NPC120220 |
0.8922 | High Similarity | NPC131866 |
0.8917 | High Similarity | NPC207729 |
0.8917 | High Similarity | NPC17816 |
0.8916 | High Similarity | NPC470704 |
0.8902 | High Similarity | NPC272722 |
0.8895 | High Similarity | NPC71260 |
0.8889 | High Similarity | NPC47883 |
0.8889 | High Similarity | NPC262286 |
0.8889 | High Similarity | NPC210084 |
0.8889 | High Similarity | NPC99597 |
0.8889 | High Similarity | NPC469584 |
0.8889 | High Similarity | NPC36852 |
0.8889 | High Similarity | NPC241904 |
0.8889 | High Similarity | NPC300727 |
0.8882 | High Similarity | NPC2928 |
0.8882 | High Similarity | NPC20541 |
0.8876 | High Similarity | NPC287243 |
0.8876 | High Similarity | NPC236327 |
0.8876 | High Similarity | NPC290304 |
0.8875 | High Similarity | NPC180234 |
0.8875 | High Similarity | NPC199100 |
0.8875 | High Similarity | NPC120537 |
0.8875 | High Similarity | NPC161277 |
0.8875 | High Similarity | NPC39007 |
0.8869 | High Similarity | NPC158226 |
0.8869 | High Similarity | NPC472584 |
0.8869 | High Similarity | NPC247964 |
0.8868 | High Similarity | NPC179183 |
0.8868 | High Similarity | NPC184136 |
0.8862 | High Similarity | NPC247136 |
0.8861 | High Similarity | NPC276930 |
0.8855 | High Similarity | NPC29160 |
0.8848 | High Similarity | NPC474350 |
0.8848 | High Similarity | NPC475985 |
0.8848 | High Similarity | NPC300984 |
0.8844 | High Similarity | NPC304322 |
0.8841 | High Similarity | NPC472275 |
0.8841 | High Similarity | NPC303565 |
0.8841 | High Similarity | NPC162668 |
0.8834 | High Similarity | NPC172770 |
0.8834 | High Similarity | NPC185258 |
0.8834 | High Similarity | NPC476242 |
0.8834 | High Similarity | NPC329091 |
0.8827 | High Similarity | NPC142339 |
0.8827 | High Similarity | NPC235165 |
0.8827 | High Similarity | NPC255106 |
0.8827 | High Similarity | NPC472461 |
0.8827 | High Similarity | NPC274730 |
0.8827 | High Similarity | NPC472916 |
0.8827 | High Similarity | NPC138243 |
0.8824 | High Similarity | NPC49667 |
0.8824 | High Similarity | NPC8127 |
0.8817 | High Similarity | NPC117450 |
0.8812 | High Similarity | NPC204515 |
0.8812 | High Similarity | NPC117579 |
0.8812 | High Similarity | NPC58668 |
0.8812 | High Similarity | NPC251110 |
0.8812 | High Similarity | NPC115324 |
0.8812 | High Similarity | NPC149614 |
0.8812 | High Similarity | NPC106372 |
0.881 | High Similarity | NPC476641 |
0.881 | High Similarity | NPC28042 |
0.881 | High Similarity | NPC281835 |
0.8802 | High Similarity | NPC234331 |
0.8802 | High Similarity | NPC320789 |
0.88 | High Similarity | NPC295436 |
0.8795 | High Similarity | NPC38914 |
0.8795 | High Similarity | NPC473286 |
0.8795 | High Similarity | NPC326520 |
0.8793 | High Similarity | NPC73929 |
0.8793 | High Similarity | NPC139683 |
0.8793 | High Similarity | NPC47905 |
0.8788 | High Similarity | NPC81679 |
0.8788 | High Similarity | NPC469575 |
0.8786 | High Similarity | NPC154527 |
0.878 | High Similarity | NPC228785 |
0.878 | High Similarity | NPC14353 |
0.878 | High Similarity | NPC200594 |
0.878 | High Similarity | NPC56085 |
0.8773 | High Similarity | NPC472914 |
0.8773 | High Similarity | NPC299520 |
0.8773 | High Similarity | NPC129684 |
0.8773 | High Similarity | NPC474208 |
0.8773 | High Similarity | NPC96167 |
0.8773 | High Similarity | NPC472911 |
0.8773 | High Similarity | NPC156057 |
0.8773 | High Similarity | NPC79053 |
0.8773 | High Similarity | NPC48208 |
0.8773 | High Similarity | NPC472913 |
0.8773 | High Similarity | NPC475267 |
0.8773 | High Similarity | NPC78225 |
0.8773 | High Similarity | NPC236796 |
0.8773 | High Similarity | NPC181960 |
0.8773 | High Similarity | NPC245758 |
0.8773 | High Similarity | NPC222814 |
0.8773 | High Similarity | NPC472910 |
0.8773 | High Similarity | NPC162869 |
0.8773 | High Similarity | NPC474836 |
0.8765 | High Similarity | NPC20830 |
0.8765 | High Similarity | NPC208197 |
0.8765 | High Similarity | NPC256612 |
0.8758 | High Similarity | NPC241498 |
0.8758 | High Similarity | NPC188203 |
0.8758 | High Similarity | NPC275722 |
0.8758 | High Similarity | NPC256283 |
0.8758 | High Similarity | NPC162313 |
0.8758 | High Similarity | NPC275836 |
0.8758 | High Similarity | NPC83508 |
0.8758 | High Similarity | NPC57030 |
0.8758 | High Similarity | NPC207624 |
0.8758 | High Similarity | NPC120163 |
0.8758 | High Similarity | NPC5871 |
0.8758 | High Similarity | NPC198826 |
0.8758 | High Similarity | NPC212678 |
0.8758 | High Similarity | NPC25270 |
0.8758 | High Similarity | NPC100887 |
0.8758 | High Similarity | NPC156222 |
0.8758 | High Similarity | NPC239128 |
0.8758 | High Similarity | NPC301323 |
0.8758 | High Similarity | NPC222830 |
0.8758 | High Similarity | NPC187498 |
0.8758 | High Similarity | NPC131624 |
0.8758 | High Similarity | NPC71334 |
0.8758 | High Similarity | NPC67654 |
0.8758 | High Similarity | NPC289968 |
0.8758 | High Similarity | NPC293183 |
0.8757 | High Similarity | NPC307286 |
0.8757 | High Similarity | NPC475964 |
0.875 | High Similarity | NPC29231 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC86477 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8704 | High Similarity | NPD2801 | Approved |
0.8659 | High Similarity | NPD3749 | Approved |
0.8642 | High Similarity | NPD1934 | Approved |
0.8598 | High Similarity | NPD4868 | Clinical (unspecified phase) |
0.8589 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8491 | Intermediate Similarity | NPD1511 | Approved |
0.8485 | Intermediate Similarity | NPD3882 | Suspended |
0.8476 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8385 | Intermediate Similarity | NPD1512 | Approved |
0.8363 | Intermediate Similarity | NPD3818 | Discontinued |
0.8343 | Intermediate Similarity | NPD6232 | Discontinued |
0.8333 | Intermediate Similarity | NPD5494 | Approved |
0.8314 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8304 | Intermediate Similarity | NPD7473 | Discontinued |
0.8294 | Intermediate Similarity | NPD3926 | Phase 2 |
0.8246 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8246 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8246 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8229 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8228 | Intermediate Similarity | NPD2344 | Approved |
0.8204 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8171 | Intermediate Similarity | NPD6559 | Discontinued |
0.8166 | Intermediate Similarity | NPD919 | Approved |
0.8144 | Intermediate Similarity | NPD7819 | Suspended |
0.8125 | Intermediate Similarity | NPD1243 | Approved |
0.8114 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.811 | Intermediate Similarity | NPD920 | Approved |
0.8107 | Intermediate Similarity | NPD7075 | Discontinued |
0.807 | Intermediate Similarity | NPD1247 | Approved |
0.8063 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8057 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8036 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8025 | Intermediate Similarity | NPD2309 | Approved |
0.8024 | Intermediate Similarity | NPD7411 | Suspended |
0.8 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD7054 | Approved |
0.8 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7988 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7988 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7955 | Intermediate Similarity | NPD7472 | Approved |
0.795 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7931 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7927 | Intermediate Similarity | NPD6799 | Approved |
0.7911 | Intermediate Similarity | NPD230 | Phase 1 |
0.791 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7901 | Intermediate Similarity | NPD2800 | Approved |
0.7895 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7882 | Intermediate Similarity | NPD5402 | Approved |
0.7879 | Intermediate Similarity | NPD2532 | Approved |
0.7879 | Intermediate Similarity | NPD2534 | Approved |
0.7879 | Intermediate Similarity | NPD2533 | Approved |
0.7875 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7866 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7865 | Intermediate Similarity | NPD7251 | Discontinued |
0.7861 | Intermediate Similarity | NPD6959 | Discontinued |
0.7857 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7857 | Intermediate Similarity | NPD6599 | Discontinued |
0.7853 | Intermediate Similarity | NPD3750 | Approved |
0.7848 | Intermediate Similarity | NPD943 | Approved |
0.7848 | Intermediate Similarity | NPD1240 | Approved |
0.7836 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7826 | Intermediate Similarity | NPD2935 | Discontinued |
0.7798 | Intermediate Similarity | NPD3226 | Approved |
0.7784 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7771 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7765 | Intermediate Similarity | NPD6801 | Discontinued |
0.776 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.775 | Intermediate Similarity | NPD1607 | Approved |
0.7722 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7716 | Intermediate Similarity | NPD2796 | Approved |
0.7688 | Intermediate Similarity | NPD447 | Suspended |
0.7663 | Intermediate Similarity | NPD4287 | Approved |
0.7607 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7576 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7561 | Intermediate Similarity | NPD2346 | Discontinued |
0.7561 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7557 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7554 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7546 | Intermediate Similarity | NPD3748 | Approved |
0.7543 | Intermediate Similarity | NPD6234 | Discontinued |
0.7542 | Intermediate Similarity | NPD3751 | Discontinued |
0.7532 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.753 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7487 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7484 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7472 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7471 | Intermediate Similarity | NPD5403 | Approved |
0.7471 | Intermediate Similarity | NPD2296 | Approved |
0.7456 | Intermediate Similarity | NPD5401 | Approved |
0.7439 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7439 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7439 | Intermediate Similarity | NPD2799 | Discontinued |
0.7427 | Intermediate Similarity | NPD1653 | Approved |
0.7425 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7425 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7418 | Intermediate Similarity | NPD5953 | Discontinued |
0.7416 | Intermediate Similarity | NPD5711 | Approved |
0.7416 | Intermediate Similarity | NPD5710 | Approved |
0.7407 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7407 | Intermediate Similarity | NPD1613 | Approved |
0.7405 | Intermediate Similarity | NPD1203 | Approved |
0.7391 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7391 | Intermediate Similarity | NPD2313 | Discontinued |
0.7362 | Intermediate Similarity | NPD1933 | Approved |
0.7356 | Intermediate Similarity | NPD37 | Approved |
0.7353 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7348 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7348 | Intermediate Similarity | NPD7228 | Approved |
0.733 | Intermediate Similarity | NPD4967 | Phase 2 |
0.733 | Intermediate Similarity | NPD4966 | Approved |
0.733 | Intermediate Similarity | NPD4965 | Approved |
0.7325 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7318 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7318 | Intermediate Similarity | NPD6808 | Phase 2 |
0.7308 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7289 | Intermediate Similarity | NPD6100 | Approved |
0.7289 | Intermediate Similarity | NPD6099 | Approved |
0.7284 | Intermediate Similarity | NPD3764 | Approved |
0.7278 | Intermediate Similarity | NPD6190 | Approved |
0.7273 | Intermediate Similarity | NPD8151 | Discontinued |
0.7256 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7246 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7222 | Intermediate Similarity | NPD3787 | Discontinued |
0.7215 | Intermediate Similarity | NPD9717 | Approved |
0.7204 | Intermediate Similarity | NPD8313 | Approved |
0.7204 | Intermediate Similarity | NPD8312 | Approved |
0.7193 | Intermediate Similarity | NPD7390 | Discontinued |
0.7189 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7178 | Intermediate Similarity | NPD3268 | Approved |
0.716 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7159 | Intermediate Similarity | NPD6280 | Approved |
0.7159 | Intermediate Similarity | NPD6279 | Approved |
0.7151 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7128 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7126 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7114 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7114 | Intermediate Similarity | NPD7783 | Phase 2 |
0.7108 | Intermediate Similarity | NPD6651 | Approved |
0.7107 | Intermediate Similarity | NPD1608 | Approved |
0.7107 | Intermediate Similarity | NPD7435 | Discontinued |
0.7088 | Intermediate Similarity | NPD5242 | Approved |
0.7086 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7081 | Intermediate Similarity | NPD2797 | Approved |
0.7073 | Intermediate Similarity | NPD411 | Approved |
0.707 | Intermediate Similarity | NPD9268 | Approved |
0.7059 | Intermediate Similarity | NPD7549 | Discontinued |
0.7056 | Intermediate Similarity | NPD5537 | Clinical (unspecified phase) |
0.7055 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7052 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7044 | Intermediate Similarity | NPD422 | Phase 1 |
0.7041 | Intermediate Similarity | NPD6777 | Approved |
0.7041 | Intermediate Similarity | NPD6776 | Approved |
0.7041 | Intermediate Similarity | NPD6780 | Approved |
0.7041 | Intermediate Similarity | NPD6778 | Approved |
0.7041 | Intermediate Similarity | NPD6781 | Approved |
0.7041 | Intermediate Similarity | NPD6782 | Approved |
0.7041 | Intermediate Similarity | NPD6779 | Approved |
0.7024 | Intermediate Similarity | NPD7033 | Discontinued |
0.7012 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7 | Intermediate Similarity | NPD8150 | Discontinued |
0.6994 | Remote Similarity | NPD9494 | Approved |
0.6983 | Remote Similarity | NPD4288 | Approved |
0.6983 | Remote Similarity | NPD5353 | Approved |
0.6982 | Remote Similarity | NPD5406 | Approved |
0.6982 | Remote Similarity | NPD5404 | Approved |
0.6982 | Remote Similarity | NPD5405 | Approved |
0.6982 | Remote Similarity | NPD5408 | Approved |
0.6975 | Remote Similarity | NPD3266 | Approved |
0.6975 | Remote Similarity | NPD3267 | Approved |
0.6974 | Remote Similarity | NPD8090 | Clinical (unspecified phase) |
0.697 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6957 | Remote Similarity | NPD4379 | Clinical (unspecified phase) |
0.6957 | Remote Similarity | NPD2403 | Approved |
0.6937 | Remote Similarity | NPD1610 | Phase 2 |
0.6937 | Remote Similarity | NPD1547 | Clinical (unspecified phase) |
0.6933 | Remote Similarity | NPD2798 | Approved |
0.6928 | Remote Similarity | NPD6233 | Phase 2 |
0.6918 | Remote Similarity | NPD17 | Approved |
0.6915 | Remote Similarity | NPD7240 | Approved |
0.6914 | Remote Similarity | NPD1940 | Clinical (unspecified phase) |
0.6914 | Remote Similarity | NPD3225 | Approved |
0.691 | Remote Similarity | NPD7615 | Clinical (unspecified phase) |
0.6906 | Remote Similarity | NPD6971 | Discontinued |
0.69 | Remote Similarity | NPD7871 | Phase 2 |
0.69 | Remote Similarity | NPD7870 | Phase 2 |
0.6897 | Remote Similarity | NPD7874 | Approved |
0.6897 | Remote Similarity | NPD7875 | Clinical (unspecified phase) |
0.689 | Remote Similarity | NPD2861 | Phase 2 |
0.6886 | Remote Similarity | NPD4307 | Phase 2 |
0.6872 | Remote Similarity | NPD6844 | Discontinued |
0.6871 | Remote Similarity | NPD1470 | Approved |
0.6867 | Remote Similarity | NPD6798 | Discontinued |
0.6867 | Remote Similarity | NPD1699 | Clinical (unspecified phase) |
0.686 | Remote Similarity | NPD2654 | Approved |
0.685 | Remote Similarity | NPD7696 | Phase 3 |
0.685 | Remote Similarity | NPD7698 | Approved |
PubChem CID   | 5281813 |
ChEMBL   | CHEMBL97453 |
ZINC   |
Molecular Weight:   | 314.04 |
ALogP:   | -1.6779 |
MLogP:   | 2.45 |
XLogP:   | 0.974 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 109.36 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 3 |
# Rings:   | 4 |
# Heavy Atoms:   | 23 |